Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial – European Heart Journal   Commentary on Twitter Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: results of randomized, double-blind, placebo-controlled, multicentre trial out.https://t.co/FYmorikQR5#HFpEF #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/4sSeYt7Adq — EHJ Editor-in-Chief (@ehj_ed) October 7, 2022 Under a […]

The post RCT | Riociguat improved hemodynamics but increased dropouts in pulmonary hypertension and HFpEF. appeared first on Links Medicus.